3.9 Article

Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update

Journal

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
Volume 58, Issue 1, Pages 102-105

Publisher

WILEY-BLACKWELL PUBLISHING, INC
DOI: 10.1111/j.1574-695X.2009.00628.x

Keywords

Mycobacterium africanum; Mycobacterium tuberculosis; the Gambia; phenotypic differences; HIV

Funding

  1. Medical Research Council
  2. NIH [TW006083]
  3. Medical Research Council [MC_U190081982, MC_U190074190, MC_U190071468, MC_U190081991] Funding Source: researchfish
  4. MRC [MC_U190071468, MC_U190074190, MC_U190081991, MC_U190081982] Funding Source: UKRI

Ask authors/readers for more resources

Mycobacterium africanum (MAF) is a common cause of human pulmonary tuberculosis in West Africa. We previously described phenotypic differences between MAF and Mycobacterium tuberculosis (MTB) among 290 patients. In the present analysis, we compared 692 tuberculosis patients infected with the two most common lineages within the (MTB) complex found in the Gambia, namely MAF West African type 2 (39% prevalence) and Euro-American MTB (55% prevalence). We identified additional phenotypic differences between infections with these two organisms. MAF patients were more likely to be older and HIV infected. In addition, they had worse disease on chest X-ray, despite complaining of cough for an equal duration, and were more likely severely malnourished. In this cohort, the prevalence of MAF did not change significantly over a 7-year period.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available